{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:52:43Z","timestamp":1781196763690,"version":"3.54.1"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The growth hormone (GH)-insulin-like growth factor-1 (IGF1) signaling pathway emerged in recent years as a key determinant of aging and longevity. Disruption of this network in different animal species, including flies, nematodes and mouse, was consistently associated with an extended lifespan. Epidemiological analyses have shown that patients with Laron syndrome (LS), the best-characterized disease under the umbrella of the congenital IGF1 deficiencies, seem to be protected from cancer. While aging and cancer, as a rule, are considered diametrically opposite processes, modern lines of evidence reinforce the notion that aging and cancer might, as a matter of fact, be regarded as divergent manifestations of identical biochemical and cellular underlying processes. While the effect of individual mutations on lifespan and health span is very difficult to assess, genome-wide screenings identified a number of differentially represented aging- and longevity-associated genes in patients with LS. The present review summarizes recent data that emerged from comprehensive analyses of LS patients and portrays a number of previously unrecognized targets for GH-IGF1 action. Our article sheds light on complex aging and longevity processes, with a particular emphasis on the role of the GH-IGF1 network in these mechanisms.<\/jats:p>","DOI":"10.3389\/fendo.2023.1291812","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T06:13:37Z","timestamp":1698214417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Insulin-like growth factors and aging: lessons from Laron syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Haim","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Laron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1530\/JME-17-0298","article-title":"Insulin-like growth factors: actions on the skeleton","volume":"61","author":"Yakar","year":"2018","journal-title":"J Mol Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0427","article-title":"Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor-1","volume":"3","author":"LeRoith","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038156","article-title":"Insulin-like growth factors and the basis of growth","volume":"349","author":"Rosenfeld","year":"2003","journal-title":"New Engl J Med"},{"key":"B4","article-title":"A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro","volume":"49","author":"Salmon","year":"1957","journal-title":"J Lab Clin Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tem.2008.03.003","article-title":"IGF signaling defects as causes of growth failure and IUGR","volume":"19","author":"Klammt","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2005.08.001","article-title":"Control of aging and longevity by IGF-I signaling","volume":"40","author":"Yang","year":"2005","journal-title":"Exp Gerontol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad225","article-title":"Hormones and aging: an endocrine society scientific statement","volume":"108","author":"Cappola","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3158","article-title":"Age-dependent decline in acyl-ghrelin concentrations and reduced association of acyl-ghrelin and growth hormone in healthy older adults","volume":"99","author":"Nass","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5328.942","article-title":"daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans","volume":"277","author":"Kimura","year":"1997","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00306-3","article-title":"A conserved regulatory system for aging","volume":"105","author":"Kenyon","year":"2001","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1057991","article-title":"Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein","volume":"292","author":"Clancy","year":"2001","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.7.7586","article-title":"Assessment of growth parameters and life span of GHR\/BP gene-disrupted mice","volume":"141","author":"Coschigano","year":"2000","journal-title":"Endocrinology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/ERC-16-0054","article-title":"Identification of signaling pathways associated with cancer protection in Laron syndrome","volume":"23","author":"Lapkina-Gendler","year":"2016","journal-title":"Endocrine Related Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/cells8060596","article-title":"Genome-wide profiling of Laron Syndrome patients identifies novel cancer protection pathways","volume":"8","author":"Werner","year":"2019","journal-title":"Cells"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.3390\/cells9112446","article-title":"Laron syndrome research paves the way for new insights in oncological investigation","volume":"9","author":"Werner","year":"2020","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-011-9340-3","article-title":"Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin\/IGF-1 signaling and telomere maintenance pathways","volume":"35","author":"Deelen","year":"2013","journal-title":"Age (Dordr)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2005.06.014","article-title":"The molecular basis of idiophatic short stature","author":"Rosenfeld","year":"2005","journal-title":"Growth Hormone IGF Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0509","article-title":"Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, The Lawson Wilkins Pediatric Endocrine Society and the European Society for Pediatric Endocrinology Workshop","volume":"93","author":"Cohen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene","volume":"335","author":"Woods","year":"1996","journal-title":"New Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"New Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013100","article-title":"Deficiency of the circulating IGF system associated with inactivation of the acid-labile subunit gene","volume":"350","author":"Domene","year":"2004","journal-title":"New Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201506106","article-title":"Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability EMBO Mol","volume":"8","author":"Dauber","year":"2016","journal-title":"Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac738","article-title":"Novel insulin-like growth factor 1 gene mutation: broadening of the phenotype and implications for insulin resistance","volume":"17","author":"Giacomozzi","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.17458\/per.vol16.2018.dd.geneticmutationsghigf","article-title":"Genetic mutations in the GH\/IGF axis","volume":"16","author":"Domen\u00e9","year":"2018","journal-title":"Pediatr Endocrinol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3390\/cells10082063","article-title":"Applying bioinformatic platforms, in vitro, and in vivo functional assays in the characterization of genetic variants in the GH\/IGF pathway affecting growth and development","volume":"10","author":"Domen\u00e9","year":"2021","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-11183-9","volume-title":"Laron Syndrome \u2013 from Man to Mouse","author":"Laron","year":"2011"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031033","article-title":"Extensive personal experience. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003","volume":"89","author":"Laron","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","article-title":"Genetic pituitary dwarfism with high serum concentration of growth hormone-a new inborn error of metabolism","volume":"2","author":"Laron","year":"1966","journal-title":"Isr J Med Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2016.08.002","article-title":"IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome","volume":"772","author":"Laron","year":"2017","journal-title":"Mutat Res Rev Mutat Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198910123211501","article-title":"Laron dwarfism and mutations of the growth hormone-receptor gene","volume":"321","author":"Amselem","year":"1989","journal-title":"New Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.20.8083","article-title":"Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism","volume":"86","author":"Godowski","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"B33","article-title":"Genetic analysis of the pedigrees and molecular defects of the GH-receptor gene in the Israeli cohort of patients with Laron syndrome","author":"Shevah","year":"2006","journal-title":"Pediatr Endocrinol Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4158\/EP15939.RA","article-title":"Lessons from 50 years of study of Laron syndrome","volume":"21","author":"Laron","year":"2015","journal-title":"Endocr Pract"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0859","article-title":"Congenital IGF1 deficiency tends to confer protection against post-natal development of Malignancies","volume":"164","author":"Steuerman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B40","first-page":"6","article-title":"Fifty years on: New lessons from Laron syndrome","volume":"19","author":"Werner","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24217","article-title":"The decline and fall of the IGF-I receptor","volume":"28","author":"Baserga","year":"2013","journal-title":"J Cell Physiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"111003","DOI":"10.1016\/j.mce.2020.111003","article-title":"Role of the GH-IGF1 system in progression of cancer","volume":"518","author":"Werner","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-814162","article-title":"The insulin-like growth factor axis in cell cycle pregression","volume":"35","author":"Dupont","year":"2003","journal-title":"Horm Metab Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1055589","article-title":"Hallmarks of cancer: The insulin-like growth factors perspective","volume":"12","author":"Werner","year":"2022","journal-title":"Front Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-017-0514-5","article-title":"Insulin-like growth factor (IGF) pathway targeting in cancer: Role of the IGF axis and opportunities for future combination studies","volume":"12","author":"Simpson","year":"2017","journal-title":"Target Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2014.07.004","article-title":"Can we unlock the potential of IGF-1R inhibition in cancer therapy","volume":"40","author":"King","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00064","article-title":"Targeting the IGF-1R: the tale of the tortoise and the hare","volume":"6","author":"Crudden","year":"2015","journal-title":"Front Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00106","article-title":"IGF-1 receptor and adhesion signaling: an important axis in determining cancer cell phenotype and therapy resistance","volume":"6","author":"Cox","year":"2015","journal-title":"Front Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1300","article-title":"The critical role of metabolic pathways in aging","volume":"61","author":"Barzilai","year":"2012","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"crossref","DOI":"10.1002\/0470846542.ch8","article-title":"Effects of growth hormone and insulin-like growth factor-1 deficiency on ageing and longevity","volume-title":"Endocrine Facets of Ageing","author":"Laron","year":"2002"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-351X(98)80023-2","article-title":"Ageing and growth hormone status","volume":"12","author":"Toogood","year":"1998","journal-title":"Bailliere\u2019s Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000182212.09147.56","article-title":"Aginh and longevity: The IGF-1 enigma","volume":"97","author":"Anversa","year":"2005","journal-title":"Circ Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1377","article-title":"Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality","volume":"96","author":"Burgers","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2138","article-title":"Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations","volume":"94","author":"Friedrich","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.05.014","article-title":"The somatotropic axis in human aging: framework for the current state of knowledge and future research","volume":"23","author":"Milman","year":"2016","journal-title":"Cell Metab"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e13443","DOI":"10.1111\/acel.13443","article-title":"The antagonistic pleiotropy of insulin-like growth factor 1","author":"Zhang","year":"2021","journal-title":"Aging Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2011.09.005","article-title":"TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms","volume":"43","author":"Zhou","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M600427200","article-title":"The interaction of thioredoxin with Txnip: Evidence for formation of a mixed disulfide by disulfide exchange","volume":"281","author":"Patwari","year":"2006","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.040913","article-title":"Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling","volume":"19","author":"Aitken","year":"2004","journal-title":"J Bone Mineral Res"},{"key":"B60","article-title":"Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP","volume":"63","author":"Goldberg","year":"2003","journal-title":"Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708169200","article-title":"Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production","volume":"283","author":"Chutkow","year":"2008","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2271","article-title":"Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1","volume":"65","author":"Jeon","year":"2005","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1177\/1947601910389604","article-title":"Transcriptional and translational downregulation of thioredoxin interacting protein is required for metabolic reprogramming during G(1)","volume":"1","author":"Elgort","year":"2010","journal-title":"Genes Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.267666","article-title":"Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability","volume":"286","author":"Chutkow","year":"2011","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.03.020","article-title":"Downregulation of TXNIP leads to high proliferative activity and estrogen-dependent cell growth in breast cancer","volume":"498","author":"Park","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715930115","article-title":"Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action","volume":"115","author":"Nagaraj","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.3390\/cells11203260","article-title":"Long-term IGF1 stimulation leads to cellular senescence via functional interaction with the thioredoxin-interacting protein, TXNIP","volume":"11","author":"Nagaraj","year":"2022","journal-title":"Cells"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810234","article-title":"Targeting senescent cells in translational medicine","volume":"11","author":"Paez-Ribes","year":"2019","journal-title":"EMBO Mol Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14969","article-title":"The clinical potential of senolytic drugs","volume":"65","author":"Kirkland","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1038\/s41467-019-13192-4","article-title":"Senescent cell turnover slows with age providing an explanation for the Gompertz law","volume":"10","author":"Karin","year":"2019","journal-title":"Nat Commun"},{"key":"B71","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/07853890701771823","article-title":"MicroRNAs: a new class of gene regulators","volume":"40","author":"Guarnieri","year":"2008","journal-title":"Ann Med"},{"key":"B72","article-title":"The impact of microRNAs on endocrinology","volume":"8","author":"Zalts","year":"2011","journal-title":"Ped Endocrinol Rev"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1126\/science.1151651","article-title":"Gene regulation by transcription factors and microRNAs","volume":"319","author":"Hobert","year":"2008","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/BJ20100859","article-title":"MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells","volume":"432","author":"Jiang","year":"2010","journal-title":"Biochem J"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.197","article-title":"A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS\/Fli1-regulated microRNAs","volume":"30","author":"McKinsey","year":"2011","journal-title":"Oncogene"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/cells10081856","article-title":"Dysregulation of miRNAs targeting the IGF-1R pathway in pancreatic ductal adenocarcinoma","volume":"10","author":"Dobre","year":"2021","journal-title":"Cells"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79052","article-title":"MicroRNA-132 enhances transition from inflammation to proliferation during wound healing","volume":"125","author":"Li","year":"2015","journal-title":"J Clin Invest"},{"key":"B78","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1038\/s41598-018-26547-6","article-title":"SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease","volume":"8","author":"Hadar","year":"2018","journal-title":"Sci Rep"},{"key":"B79","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","article-title":"Sirt1 and the mitochondria","volume":"39","author":"Tang","year":"2016","journal-title":"Mol Cells"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15570","article-title":"Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders","volume":"179","author":"Leite","year":"2022","journal-title":"Br J Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1210\/me.2009-0117","article-title":"MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1","volume":"23","author":"Strum","year":"2009","journal-title":"Mol Endocrinol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-210132","article-title":"The protective mechanism of SIRT1 in the regulation of mitochondrial biogenesis and mitochondrial autophagy in Alzheimer's Disease","volume":"82","author":"Ye","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200729111744","article-title":"SIRT1 promotes neuronal fortification in neurodegenerative diseases through attenuation of pathological hallmarks and enhancement of cellular lifespan","volume":"19","author":"Mishra","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12219","article-title":"Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence","volume":"13","author":"Tran","year":"2014","journal-title":"Aging Cell"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1291812\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T06:13:43Z","timestamp":1698214423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1291812\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":84,"alternative-id":["10.3389\/fendo.2023.1291812"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1291812","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,24]]},"article-number":"1291812"}}